Close
4

Quotient Sciences Quotient Sciences

X

Company profile for Corvidia Therapeutics

  • Webinars & Exhibitions

PharmaCompass
About the Company
Corvidia Therapeutics is a clinical stage company focused on the research, development and commercialization of transformative therapies for cardio-renal diseases. After receiving seed funding from Sofinnova Partners in 2015, our company was founded around a pipeline of assets with best in class potential to make a positive impact on patients with cardio-renal diseases. Since then, we have raised $26 million in Series A fin...
Corvidia Therapeutics is a clinical stage company focused on the research, development and commercialization of transformative therapies for cardio-renal diseases. After receiving seed funding from Sofinnova Partners in 2015, our company was founded around a pipeline of assets with best in class potential to make a positive impact on patients with cardio-renal diseases. Since then, we have raised $26 million in Series A financing led by Sofinnova Partners and Apple Tree Partners and, $60 million in Series B financing led by Venrock which included Andera Partners, Cormorant Asset Management, HBM Partners & Fresenius Medical Care Ventures.

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
Corvidia Therapeutics
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
35 Gatehouse Drive Waltham, MA 02451
Telephone
Telephone
1-781-205-4755
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY